Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer REPLY

被引：0

作者：

Goy, Barry W. ^{[1
]}

机构：

[1] Kaiser Permanente, Los Angeles Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90027 USA

来源：

UROLOGY | 2020年 / 136卷

关键词：

ASCENDE-RT; TRIAL; BOOST;

D O I：

10.1016/j.urology.2019.09.043

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：189 / 189

页数：1

共 5 条

[1]

Goy BW, 2019, P AM SOC CLIN ONCOLO

[2] Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer [J].

Morris, W. James ;

Tyldesley, Scott ;

Rodda, Sree ;

Halperin, Ross ;

Pai, Howard ;

McKenzie, Michael ;

Duncan, Graeme ;

Morton, Gerard ;

Hamm, Jeremy ;

Murray, Nevin .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02) :275-285

[3] Brachytherapy: Where Has It Gone? [J].

Petereit, Daniel G. ;

Frank, Steven J. ;

Viswanathan, Akila N. ;

Erickson, Beth ;

Eifel, Patricia ;

Nguyen, Paul L. ;

Wazer, David E. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :980-+

[4] Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma [J].

Prestidge, B. R. ;

Winter, K. ;

Sanda, M. G. ;

Amin, M. ;

Bice, W. S., Jr. ;

Michalski, J. ;

Ibbott, G. S. ;

Crook, J. M. ;

Catton, C. N. ;

Gay, H. A. ;

Donavanik, V. ;

Beyer, D. C. ;

Frank, S. J. ;

Papagikos, M. A. ;

Rosenthal, S. A. ;

Barthold, H. J. J., II ;

Roach, M., III ;

Sandler, H. M. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02) :S4-S4

[5] ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High-and Intermediate-Risk Prostate Cancer [J].